CN103230409B - Medicine for treating intestinal diseases and application - Google Patents
Medicine for treating intestinal diseases and application Download PDFInfo
- Publication number
- CN103230409B CN103230409B CN201310171032.3A CN201310171032A CN103230409B CN 103230409 B CN103230409 B CN 103230409B CN 201310171032 A CN201310171032 A CN 201310171032A CN 103230409 B CN103230409 B CN 103230409B
- Authority
- CN
- China
- Prior art keywords
- injection
- medicine
- troxerutin
- calcium lactate
- citicolini
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
The invention discloses a medicine for treating intestinal diseases. The medicine is prepared by the raw materials in parts by weight as follows: 1-3 parts of nicholin injection, 1-2.5 parts of troxerutin injection and 1-4 parts of calcium lactate injection, wherein the nicholin injection comprises 5.0g of nicholin in every 100ml of injection; the troxerutin injection comprises 5.0g of troxerutin in every 100ml of injection; and the calcium lactate injection comprises 5.0g of calcium lactate in every 100ml of injection. The medicine is used to treat non-specific colonitis and intestinal obstruction. The medicine disclosed by the invention has the complete effect of non-surgical treatment for treating intestinal obstruction and non-specific colonitis, and the cure rate is higher than 90%.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of intestinal tract disease.
Background technology
Nonspecific colonitis, is decided to be difficult disease by domestic and international medical profession, and the sickness rate of this disease is high, and does not have specific drug both at home and abroad.
Intestinal obstruction is sick, and made mortality rate is more than 25%, and various big hospital all adopts operative treatment, and recurrence after operation rate is high, is called as adhesive ileus, torments patient, has consumed again a large amount of medical resources simultaneously.
Summary of the invention
The present invention is directed to the deficiencies in the prior art, a kind of medicine for the treatment of intestinal tract disease is provided.
For achieving the above object, the technical solution used in the present invention is:
Treat a medicine for intestinal tract disease, by following raw material by volume part proportioning make:
Injection Citicolini 1 ~ 3 part
Troxerutin injection 1 ~ 2.5 part
Calcium lactate injection 1 ~ 4 part
Described injection Citicolini is containing citicoline 5.0g in every 100ml injection;
Described troxerutin injection is containing troxerutin 5.0g in every 100ml injection;
Described calcium lactate injection is that the preparation method of calcium lactate injection is: take 5.0g calcium lactate and be dissolved in 100 ml physiological salines containing calcium lactate 5.0g in every 100ml injection.
The application of above-mentioned medicine in treatment nonspecific colonitis and intestinal obstruction.
Beneficial effect of the present invention: medicine of the present invention is in treatment intestinal obstruction and nonspecific colonitis, and obtain the satisfactory effect of non-operative treatment, cure rate is higher than 90%.
A kind of medicine for the treatment of intestinal tract disease of the present invention is used for the treatment of ileac clinical setting:
(1) physical data:
Intestinal obstruction patient 100 example, wherein: male 45 example, women 55 example; 92 years old the highest age, 12 years old minimum age.
(2) diagnostic criteria:
Symptom: 1. around umbilicus, paroxysmal abdominal pain increases the weight of gradually;
2. vomit;
3. abdominal distention;
4. defecation and aerofluxus stop;
5. General Symptoms: thirsty, oliguria, rapid pulse are accelerated, irritated, shock.
Have a medical check-up: after blocking 4 ~ 6 hours, X-ray claps plain abdominal radiograph, and vertical position sees that the multiple fluid level of enteric cavity is that ladder sample changes.
Diagnostic criteria: possess three in above-mentioned symptom, and visible abdominal part X-ray P-A Cephalomatrics has fluid level person to make a definite diagnosis.
(3) Therapeutic Method:
Get injection Citicolini 2 ~ 6ml respectively, wherein contain citicoline 5.0g in every 100 ml injection Citicolini, troxerutin injection 2 ~ 5ml, wherein contain troxerutin 5.0g in every 100ml troxerutin injection, calcium lactate injection 2 ~ 8ml, wherein contains calcium lactate 5.0g in every 100ml calcium lactate injection, will join in 250 milliliters of isotonic glucoses or normal saline after three kinds of injection mixing, vein input every day once, uses 15 ~ 20 days continuously.
(4) efficacy assessment standard:
Cure: General Symptoms disappears, and defecation is unobstructed, without abdominal distention, stomachache, X-ray is clapped the flat sign of normotopia plain abdominal radiograph liquid and is disappeared.
Take a turn for the better: vomiting disappears, a small amount of defecation of energy, aerofluxus, other symptom disappears not yet completely.
Invalid: clinical symptoms is without improvement, and X-ray film making still has fluid level sign as seen.
(5) therapeutic outcome:
A kind of medicine for the treatment of intestinal tract disease of the present invention is used for the treatment of the clinical setting of nonspecific colonitis:
(1) physical data:
Nonspecific colonitis patient 100 example, male: 72 examples; Women: 28 examples; 30 ~ 54 years old age.
(2) diagnostic criteria:
Symptom: 1. chronic diarrhea every day 3 ~ 20 times;
2. mucus is had in feces;
3. hemafecia;
4. multidigit is in left lower abdomen spasmodic colic;
5. malaise, become thin, anemia;
6. obstipation (maintaining defecation by cathartic).
Have a medical check-up: colonoscope can see colon district myxedema, hyperemia, petechia or polyp, ulcer;
Standard is made a definite diagnosis in diagnosis: above-mentioned symptom possesses three, simultaneously in conjunction with colonoscopy report, can make a definite diagnosis.
(3) Therapeutic Method:
Get injection Citicolini 2 ~ 6ml respectively, wherein contain citicoline 5.0g in every 100 ml injection Citicolini, troxerutin injection 2 ~ 5ml, wherein contain troxerutin 5.0g in every 100ml troxerutin injection, calcium lactate injection 2 ~ 8ml, wherein contains calcium lactate 5.0g in every 100ml calcium lactate injection, will join in 250 milliliters of isotonic glucoses or normal saline after three kinds of injection mixing, vein input every day once, uses 15 ~ 20 days continuously.
(4) efficacy assessment standard:
Cure: symptom all disappears, colonoscopy report without exception.
Take a turn for the better: stool molding, hemafecia disappears, and just subnormal, other symptom disappears not yet completely.
Invalid: to change (symptom, coherence check) with medical front ratio without any improvement.
(5) therapeutic outcome:
Detailed description of the invention
Embodiment 1 one kinds treats the medicine of intestinal tract disease, by following raw material by volume part proportioning make:
Injection Citicolini 1 part
Troxerutin injection 1 part
Calcium lactate injection 1 part
Described injection Citicolini is containing citicoline 5.0g in every 100ml normal saline solution;
Described troxerutin injection is containing troxerutin 5.0g in every 100ml normal saline solution;
Described calcium lactate injection is containing calcium lactate 5.0g in every 100ml normal saline solution.
Above-mentioned medicine is used for the treatment of nonspecific colonitis and intestinal obstruction.
Embodiment 2 one kinds treats the medicine of intestinal tract disease, by following raw material by volume part proportioning make:
Injection Citicolini 3 parts
Troxerutin injection 1 part
Calcium lactate injection 2 parts
Described injection Citicolini is containing citicoline 5.0g in every 100ml normal saline solution;
Described troxerutin injection is containing troxerutin 5.0g in every 100ml normal saline solution;
Described calcium lactate injection is containing calcium lactate 5.0g in every 100ml normal saline solution.
Above-mentioned medicine is used for the treatment of nonspecific colonitis and intestinal obstruction.
Embodiment 3 one kinds treats the medicine of intestinal tract disease, by following raw material by volume part proportioning make:
Injection Citicolini 1 part
Troxerutin injection 2.5 parts
Calcium lactate injection 4 parts
Described injection Citicolini is containing citicoline 5.0g in every 100ml normal saline solution;
Described troxerutin injection is containing troxerutin 5.0g in every 100ml normal saline solution;
Described calcium lactate injection is containing calcium lactate 5.0g in every 100ml normal saline solution.
Above-mentioned medicine is used for the treatment of nonspecific colonitis and intestinal obstruction.
Claims (2)
1. treat a medicine for intestinal tract disease, it is characterized in that by following raw material by volume part proportioning make:
Injection Citicolini 1 ~ 3 part
Troxerutin injection 1 ~ 2.5 part
Calcium lactate injection 1 ~ 4 part
Described injection Citicolini is containing citicoline 5.0g in every 100ml injection;
Described troxerutin injection is containing troxerutin 5.0g in every 100ml injection;
Described calcium lactate injection is containing calcium lactate 5.0g in every 100ml injection.
2. the application of medicine according to claim 1 in preparation treatment nonspecific colonitis and intestinal obstruction medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310171032.3A CN103230409B (en) | 2013-05-10 | 2013-05-10 | Medicine for treating intestinal diseases and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310171032.3A CN103230409B (en) | 2013-05-10 | 2013-05-10 | Medicine for treating intestinal diseases and application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103230409A CN103230409A (en) | 2013-08-07 |
| CN103230409B true CN103230409B (en) | 2014-12-31 |
Family
ID=48878527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310171032.3A Active CN103230409B (en) | 2013-05-10 | 2013-05-10 | Medicine for treating intestinal diseases and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103230409B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106420773A (en) * | 2016-12-21 | 2017-02-22 | 郑州莉迪亚医药科技有限公司 | Chinese and western medicinal composition for treating radioactive enteritis, and preparation method and application thereof |
| JP7290870B2 (en) | 2018-01-12 | 2023-06-14 | メティメディ ファーマシューティカルズ カンパニー リミテッド | Methods of treating chronic inflammatory diseases |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1663569A (en) * | 2004-03-06 | 2005-09-07 | 杨喜鸿 | Fructose injection for cardiovascular medicine |
| CN101019854A (en) * | 2006-02-16 | 2007-08-22 | 北京奇源益德药物研究所 | Compound coenzyme Q10 medicine prepn and its prepn process and application |
-
2013
- 2013-05-10 CN CN201310171032.3A patent/CN103230409B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN103230409A (en) | 2013-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101780254B (en) | Traditional Chinese medicine compound for treating intestinal tumor | |
| CN103230409B (en) | Medicine for treating intestinal diseases and application | |
| CN100427080C (en) | Enteroclysis contg. sodium azulene-sulfonate | |
| CN102579621A (en) | Chinese medicinal preparation for treating urinary calculus of goat | |
| CN102526640B (en) | Pantoprazole sodium medicine compound and preparation technology thereof | |
| CN100546611C (en) | A kind of Chinese medicine preparation for the treatment of acquired immune deficiency syndrome (AIDS) | |
| CN103156961B (en) | Medicine composition used for treating common cold, wind cold, and lung and stomach heat stagnation | |
| CN102362897B (en) | Use of Hulisan Jiaonang in preparation of medicine for treating scabies | |
| CN1857563A (en) | Colon locating administrated dragon's blood preparation and its application | |
| CN100355436C (en) | Tibetan medicine for treating women's diseases, and its preparing method | |
| CN103566225B (en) | Medicament for treating gynecological postoperative gastrointestinal dysfunction | |
| CN104306948A (en) | Medicament composition for treating gouty arthritis | |
| CN108939011A (en) | A kind of Chinese herbal medicine formula for the treatment of cancer | |
| CN103784521A (en) | Traditional Chinese medicinal composition for treating abdominal absdcess in combination with operative treatment and preparation method thereof | |
| CN102406728B (en) | Medicinal composition for treating lymphaden inflammations | |
| CN102366567B (en) | Pharmaceutical composition for treating condyloma acuminatum, and preparation and application method | |
| CN101618205B (en) | Medicine composition for treating cold in types of wind cold and exterior syndrome of deficiency and preparation method thereof | |
| CN102240360A (en) | Bowel clearing and detoxifying infusion | |
| CN101264268B (en) | Proprietary Chinese medicine for treating tumor | |
| CN105853940A (en) | Traditional Chinese medicine for treating bile disease | |
| CN105535793A (en) | Traditional Chinese medicinal composition for treating hemorrhoids | |
| CN105147930B (en) | The leech compound preparation for treating salpingemphraxis | |
| CN106309585B (en) | A kind of Chinese medicine composition improving tumor patient ostalgia and its application in analgesia | |
| CN117045756A (en) | Traditional Chinese medicine composition and medical application thereof | |
| RU2419422C1 (en) | Method of correcting functional biliary tract disorders in children with acute intestinal infections |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |